Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 4, Number 4—December 1998

Synopsis

Chlamydia pneumoniae and Cardiovascular Disease

Lee Ann Campbell, Cho-Chou Kuo, and J. Thomas Grayston
Author affiliations: University of Washington, Seattle, Washington, USA

Main Article

Figure 2

Immunocytochemical staining demonstrating Chlamydia pneumoniae in fibrolipid plaque from coronary artery atheroma. Panel A illustrates positive staining of foam cells in the plaque with the C. pneumoniae—specific monoclonal antibody TT-401. Panel B shows negative staining of the adjacent section using normal ascites fluid as the control.

Figure 2. Immunocytochemical staining demonstrating Chlamydia pneumoniae in fibrolipid plaque from coronary artery atheroma. Panel A illustrates positive staining of foam cells in the plaque with the C. pneumoniae—specific monoclonal antibody TT-401. Panel B shows negative staining of the adjacent section using normal ascites fluid as the control.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO